Tyeese L. Gaines DO
Dr. Tyeese L. Gaines, is a board-certified emergency medicine physician as well as a 15-year news veteran. Dr. Ty has a master's degree in journalism from Northeastern University and previously served as health editor of theGrio.com (Formerly MSNBC) for 3 years.
After interning at media outlets such as WAVE3 (NBC) in Louisville and WCVB (ABC) in Boston, she got her start as an associate producer for NBC6/WTVJ in Miami during medical school. Over the years, Dr. Ty has appeared as an on-air medical expert for local, online and national news shows and has written for various online, magazine and newspaper outlets. In 2011 was honored with a Top 40 under 40 award from the National Medical Association and she recently finished her Master of Business Administration degree from University of North Carolina - Chapel Hill.
Dr. Ty is a practicing emergency medicine physician. She completed her residency training at Yale-New Haven Hospital where she was chief resident, and later taught as a clinical instructor.
After interning at media outlets such as WAVE3 (NBC) in Louisville and WCVB (ABC) in Boston, she got her start as an associate producer for NBC6/WTVJ in Miami during medical school. Over the years, Dr. Ty has appeared as an on-air medical expert for local, online and national news shows and has written for various online, magazine and newspaper outlets. In 2011 was honored with a Top 40 under 40 award from the National Medical Association and she recently finished her Master of Business Administration degree from University of North Carolina - Chapel Hill.
Dr. Ty is a practicing emergency medicine physician. She completed her residency training at Yale-New Haven Hospital where she was chief resident, and later taught as a clinical instructor.
Recent Contributions to PracticeUpdate:
- Talazoparib in Patients With Advanced Breast Cancer and Germline BRCA Mutation
- Genomically Targeted Therapies in Neuro-Oncology
- ESMO 2018: Key Practice Impacting Trials on Prostate Cancer
- ESMO 2018: Implications of New Cancer Cachexia Guidelines
- ESMO 2018: Social and Behavioral Indicators of Lung Cancer Screening
- ESMO 2018: Abiraterone in High and Low Risk, Hormone Sensitive Metastatic Prostate Cancer
- ESMO 2018: Genomic Landscape in Early Stage Lung Cancer
- ESMO 2018: New Approaches to Advanced Triple Negative Breast Cancer
- ESMO 2018: SL-701, A Novel Peptide-Based Immunotherapy for Recurrent Glioblastoma
- ESMO 2018: Implications of New Data on Biosimilars